as on January 28, 2026 at 9:41 pm IST
Day's Low
Day's High
2.74%
Downside
0.75%
Upside
52 Week's Low
52 Week's High
2.07%
Downside
143.27%
Upside
Check Legend Biotech Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$3.5B
EPS (TTM)
-1.4072
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-181.2M
Revenue (TTM)
909.0M
Profit Margin
-26.37%
Return On Equity TTM
-22.53%
Compare market cap, revenue, PE, and other key metrics of Legend Biotech Corp with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $3.5B | -29.05% | NA | -26.37% | |
| BUY | $47.7B | 129.26% | 1246.03 | 1.36% | |
| BUY | $122.3B | 106.13% | 33.56 | 31.35% | |
| NA | $37.4B | NA | 662.33 | 1.38% | |
| BUY | $80.8B | 52.34% | 18.28 | 32.13% |
The Legend Biotech Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Legend Biotech Corp investment value today
Current value as on today
₹57,682
Returns
Returns from Legend Biotech Corp Stock
Dollar Returns*
₹5,974 (+5.97%)
Based on 27 analysts
88.89%
Buy
11.11%
Hold
0.00%
Sell
Based on 27 analysts, 88.89% of analysts recommend a 'BUY' rating for Legend Biotech Corp. Average target price of $66.32
Get share price movements and forecasts by analysts on Legend Biotech Corp.
What analysts predicted
71.92%UPSIDE
Target Price
$66.32
Current Price
$18.62
Analyzed by
27 Analysts
Target
$66.32
Legend Biotech Corp target price $66.32, a slight upside of 71.92% compared to current price of $18.62. According to 27 analysts rating.
Investment in Legend Biotech Corp Shares on INDmoney has dropped by -10.82% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Legend Biotech Corp Stock has increased by 20% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:20% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 12 November
Wed, 06:02 PM
-Legend Biotech reports Q3 2025 results, highlighting CARVYKTI sales growth and regulatory updates, with a net loss of $39.7 million.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 5 quarters, 160.20M → 272.33M (in $), with an average increase of 12.1% per quarter
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -125.38M → -39.68M (in $), with an average increase of 215.9% per quarter
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 48.3% return, outperforming this stock by 97.6%
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 29.4% return, outperforming this stock by 94.7%
Price Dip
![]()
In the last 7 days, LEGN stock has moved down by -12.0%
| Organisation | Legend Biotech Corp |
| Headquarters | 2101 Cottontail Lane, Somerset, NJ, United States, 08873 |
| Industry | Commercial Services |
| CEO | Dr. Ying Huang Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Ying Huang Ph.D. | CEO & Director |
Mr. James Pepin J.D. | General Counsel |
Mr. Tim Roberts | Global Compliance Officer |
Surabhi Verma | Manager of Investor Relations & Corporate Communications |
Mr. Carlos Santos | Chief Financial Officer |
Ms. Jessie Yeung M.B.A. | Vice President of Finance, Investor & Public Relations |
Ms. Elaine Qian | VP & Global Head of Human Resources |
Dr. Guowei Fang Ph.D. | President of Research & Development |
Mr. Birk Vanderweeen | Senior Vice President of Global Manufacturing & Supply |
Mr. Alan S. Bash | President of CARVYKTI® |
Legend Biotech Corp share price today is $18.62 as on . Legend Biotech Corp share today touched a day high of $18.76 and a low of $18.11.
Legend Biotech Corp share touched a 52 week high of $45.3 on and a 52 week low of $18.24 on . Legend Biotech Corp stock price today i.e. is trending at $18.62,which is 58.89% down from its 52 week high and 2.11% up from its 52 week low.
Legend Biotech Corp market capitalisation is $0.00T as on .
Indian investors can start investing in Legend Biotech Corp (LEGN) shares with as little as ₹91.762 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹917.62 in Legend Biotech Corp stock (as per the Rupee-Dollar exchange rate as on ).
Based on Legend Biotech Corp share’s latest price of $18.62 as on January 28, 2026 at 9:41 pm IST, you will get 0.5371 shares of Legend Biotech Corp. Learn more about
fractional shares .
Legend Biotech Corp stock has given -29.05% share price returns and 25.73% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?